PMID- 30001302 OWN - NLM STAT- MEDLINE DCOM- 20190626 LR - 20221207 IS - 1175-8716 (Electronic) IS - 0028-8446 (Linking) VI - 131 IP - 1478 DP - 2018 Jul 13 TI - Comparing methamphetamine, MDMA, cocaine, codeine and methadone use between the Auckland region and four Australian states using wastewater-based epidemiology (WBE). PG - 12-20 AB - AIMS: To compare levels of drug use in Auckland with four Australian major cities using wastewater-based epidemiology (WBE). METHODS: A week of daily wastewater samples were selected from two Auckland and eight Australian urban wastewater treatment plants (WWTPs) during 2014 and 2015. Samples were analysed for drug residues using liquid chromatography-tandem mass spectrometry. Consumption of methamphetamine, methylenedioxymethamphetamine (MDMA), cocaine, codeine and methadone (mg/day/1,000 people) was estimated for each WWTP from mass loads using an internationally validated back-calculation formula. RESULTS: Cocaine was not detected at either of the two Auckland WTTPs, and MDMA was detected on only one day of the sampled week in each of the Auckland WWTPs. In contrast, cocaine and MDMA was detected on every day at all eight Australian WWTPs. Methamphetamine was detected on every day at both the New Zealand and Australian WWTPs. Levels of methamphetamine consumption at the Auckland WWTPs were lower than five of the Australian WWTPs. Lower levels of codeine and methadone consumption were detected in Auckland than Australian sites. CONCLUSIONS: MDMA and cocaine use is low in Auckland compared to sampled Australia cities. Both Auckland and the selected Australian cities have significant methamphetamine problems compared to many European cities. FAU - Wilkins, Chris AU - Wilkins C AD - Drug Research Team Leader, SHORE & Whariki Research Centre, College of Health, Massey University. FAU - Lai, Foon Yin AU - Lai FY AD - Honorary Research Fellow, Marie Sklodowska-Curie Fellow (EU Commission), Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, Australia; Toxicological Center, Department of Pharmaceutical Sciences, University of Antwerp, Belgium. FAU - O'Brien, Jake AU - O'Brien J AD - Postdoctoral Research Fellow, Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, Australia. FAU - Thai, Phong AU - Thai P AD - Research Fellow, International Laboratory for Air Quality & Health, Queensland University of Technology, Australia. FAU - Mueller, Jochen F AU - Mueller JF AD - Group Leader, Queensland Alliance for Environmental Health Sciences (QAEHS), The University of Queensland, Australia. LA - eng PT - Journal Article DEP - 20180713 PL - New Zealand TA - N Z Med J JT - The New Zealand medical journal JID - 0401067 RN - 0 (Waste Water) RN - 0 (Water Pollutants, Chemical) RN - 44RAL3456C (Methamphetamine) RN - I5Y540LHVR (Cocaine) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - UC6VBE7V1Z (Methadone) RN - UX6OWY2V7J (Codeine) SB - IM MH - Australia/epidemiology MH - Chromatography, Liquid MH - Cities MH - Cocaine/analysis MH - Codeine/analysis MH - Humans MH - Methadone/analysis MH - Methamphetamine/analysis MH - N-Methyl-3,4-methylenedioxyamphetamine MH - New Zealand/epidemiology MH - Substance-Related Disorders/*epidemiology MH - Tandem Mass Spectrometry MH - Wastewater/*analysis MH - Water Pollutants, Chemical/*analysis COIS- Nil. EDAT- 2018/07/13 06:00 MHDA- 2019/06/27 06:00 CRDT- 2018/07/13 06:00 PHST- 2018/07/13 06:00 [entrez] PHST- 2018/07/13 06:00 [pubmed] PHST- 2019/06/27 06:00 [medline] PST - epublish SO - N Z Med J. 2018 Jul 13;131(1478):12-20.